MUMBAI, April 16, 2020: Tata Consultancy Services (BSE: 532540, NSE: TCS), the leading global IT services, consulting and business solutions organization in India, reported its consolidated financial results according to Ind AS and IFRS, for the quarter and financial year ending March 31, 2020.
The company posted 2.75 per cent growth in net income at Rs 32,340 crore For the full financial year ended March 31. The shared of the company was trading at Rs 1,694.20, down Rs 40.95 or 2.36 per cent.
TCS has over 448,000 of the world’s best-trained consultants in 46 countries. The company generated consolidated revenues of US $22 billion in the fiscal year ended March 31, 2020.
Annual Revenue $22.031 Bn, +5.3% YoY (+7.1% in CC)
Full Year Growth led by Life Sciences & Healthcare (+16.8% YoY), Europe (+14.6% YoY) and UK (+10.4% YoY)
Full Year Net Income: $4.541 Bn, +1.1% YoY
Q4 Total Contract Value: $8.9 Bn
Rajesh Gopinathan, Chief Executive Officer and Managing Director, said: “The pandemic completely reversed the positive momentum that we had started seeing in some of our biggest verticals in the first half of the quarter. On the positive side, we had very strong deal closures during the quarter. In fact, our order book this quarter is the largest ever, from the time we started reporting the metric. Organizations across the world are realizing the need for operational and systems resilience. Many of the large deals we signed during the quarter address precisely that need. They are core transformation programs that leverage the power of technology to make our customers’ operations leaner, faster, and more resilient.”
The company posted 2.75 per cent growth in net income at Rs 32,340 crore For the full financial year ended March 31. The shared of the company was trading at Rs 1,694.20, down Rs 40.95 or 2.36 per cent.
TCS has over 448,000 of the world’s best-trained consultants in 46 countries. The company generated consolidated revenues of US $22 billion in the fiscal year ended March 31, 2020.
Report Highlights:
Annual Revenue $22.031 Bn, +5.3% YoY (+7.1% in CC)
Full Year Growth led by Life Sciences & Healthcare (+16.8% YoY), Europe (+14.6% YoY) and UK (+10.4% YoY)
Full Year Net Income: $4.541 Bn, +1.1% YoY
Q4 Total Contract Value: $8.9 Bn
Rajesh Gopinathan, Chief Executive Officer and Managing Director, said: “The pandemic completely reversed the positive momentum that we had started seeing in some of our biggest verticals in the first half of the quarter. On the positive side, we had very strong deal closures during the quarter. In fact, our order book this quarter is the largest ever, from the time we started reporting the metric. Organizations across the world are realizing the need for operational and systems resilience. Many of the large deals we signed during the quarter address precisely that need. They are core transformation programs that leverage the power of technology to make our customers’ operations leaner, faster, and more resilient.”
Comments
Post a Comment